Citation: Mh. Eckman et al., MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES, Chest, 114(5), 1998, pp. 699-714
Citation: Hj. Levine et Wh. Gaasch, VASOACTIVE DRUGS IN CHRONIC REGURGITANT LESIONS OF THE MITRAL AND AORTIC VALVES, Journal of the American College of Cardiology, 28(5), 1996, pp. 1083-1091
Citation: Mh. Eckman et al., MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES, Chest, 108(4), 1995, pp. 457-470
Citation: Mh. Eckman et al., VARIATION IN THE PROTHROMBIN-TIME RATIO DURING ORAL ANTICOAGULATION -REPLY, The New England journal of medicine, 330(7), 1994, pp. 510-510
Citation: Mh. Eckman et al., EFFECT OF LABORATORY VARIATION IN THE PROTHROMBIN-TIME RATIO ON THE RESULTS OF ORAL ANTICOAGULANT-THERAPY, The New England journal of medicine, 329(10), 1993, pp. 696-702